Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18313304rdf:typepubmed:Citationlld:pubmed
pubmed-article:18313304lifeskim:mentionsumls-concept:C1367731lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C1150587lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C1705632lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C1880355lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:18313304lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:18313304pubmed:issue8lld:pubmed
pubmed-article:18313304pubmed:dateCreated2008-4-24lld:pubmed
pubmed-article:18313304pubmed:abstractTextA novel series of 4-phenylisoquinolones were synthesized and evaluated as c-Jun N-terminal kinase (JNK) inhibitors. Initial modification at the 2- and 3-positions of the isoquinolone ring of hit compound 4, identified from high-throughput screening, led to the lead compound 6b. The optimization was carried out using a JNK1-binding model of 6b and several compounds exhibited potent JNK inhibition. Among them, 11g significantly inhibited cardiac hypertrophy in rat pressure-overload models without affecting blood pressure and the concept of JNK inhibitors as novel therapeutic agents for heart failure was confirmed.lld:pubmed
pubmed-article:18313304pubmed:languageenglld:pubmed
pubmed-article:18313304pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313304pubmed:citationSubsetIMlld:pubmed
pubmed-article:18313304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313304pubmed:statusMEDLINElld:pubmed
pubmed-article:18313304pubmed:monthAprlld:pubmed
pubmed-article:18313304pubmed:issn1464-3391lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:JudsonIIlld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:YamaguchiMasa...lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:ItohFumioFlld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:KimuraHiroyuk...lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:SogabeSatoshi...lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:TamuraTomokoTlld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:TanakaToshima...lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:KawamotoTomoh...lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:MatsumotoShin...lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:AsanoYasutomi...lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:KitamuraShuji...lld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:OhraTaiichiTlld:pubmed
pubmed-article:18313304pubmed:authorpubmed-author:AsoKazuyoshiKlld:pubmed
pubmed-article:18313304pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18313304pubmed:day15lld:pubmed
pubmed-article:18313304pubmed:volume16lld:pubmed
pubmed-article:18313304pubmed:ownerNLMlld:pubmed
pubmed-article:18313304pubmed:authorsCompleteYlld:pubmed
pubmed-article:18313304pubmed:pagination4715-32lld:pubmed
pubmed-article:18313304pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:meshHeadingpubmed-meshheading:18313304...lld:pubmed
pubmed-article:18313304pubmed:year2008lld:pubmed
pubmed-article:18313304pubmed:articleTitleDiscovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).lld:pubmed
pubmed-article:18313304pubmed:affiliationMedicinal Chemistry Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd, 17-85, Jusohonmachi 2-chome, Osaka 532-8686, Japan. Asano_Yasutomi@takeda.co.jplld:pubmed
pubmed-article:18313304pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18313304lld:chembl